Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks versus Epoetin Alfa Every Week for Cancer Patients with Anemia due to the Effect of Concomitant Myelosuppressive Chemotherapy
**Background:** Anemia is a common complication among patients with cancer receiving chemotherapy and can cause significant costs to health plans. **Objective:** The objective of this study is to estimate the annual budget impact of drug treatment associated with treating cancer patients with anemi...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2015-11-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9836 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|